Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and CE information More Information
This activity will review the latest PK recommendations for Factor VIII and IX replacement and how to use and interpret PK parameters to assess treatment plans.
Choose from the criteria below to find an activity that fits you best.
|This is a product jointly developed by the National Association of Specialty
Center for Specialty Pharmacy Education (CSPE)
and the Society of Infectious Diseases Pharmacists Education Center (SIDPEC)
NOTE: If you attended the live CE webinar titled "HIV 101: Overview of the Physiologic Impact of HIV and Its Diagnosis" that was held on July 13, 2016 AND received CE credit (i.e. a nurse CE certificate or a pharmacist CE statement with ACPE Universal Activity Number 0221-9999-16-124-L01-P), you are NOT allowed to also receive CE credit for this home-study activity.
This activity provides pharmacists, nurses, and allied healthcare providers with a contextual overview of HIV diagnostics, epidemiology, and economics in both adult and adolescent populations. Worldwide and U.S. incidence of HIV is compared along with transmission vectors, mortality rates, and economic impact of the disease. There is a discussion of current HIV testing options, as well as which sub-populations should be tested and when.
The target audience for this activity includes pharmacists and nurses. Upon completion of this activity, participants will be able to:
Melissa Badowski, PharmD, BCPS, AAHIVP
Clinical Assistant Professor, Pharmacy Practice
University of Illinois at Chicago, College of Pharmacy
It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants the existence of any significant financial interest or any other relationship with the manufacturer of any commercial product(s) discussed in an educational presentation. Melissa Badowski has no relevant commercial and/or financial relationships to disclose.
Please note: The opinions expressed in this activity should not be construed as those of the CME/CE provider. The information and views are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include unlabeled indications. Use of drugs and devices outside of labeling should be considered experimental and participants are advised to consult prescribing information and professional literature.
Release Date: 07-13-2016
Expiration Date: 07-13-2018
This CE activity is jointly provided by ProCE, Inc., NASP’s Center for Specialty Pharmacy Education (CSPE™), and the Society of Infectious Diseases Pharmacists’ SIDP Education Center (SIDPEC™). ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-16-125-H01-P has been assigned to this knowledge-based, home-study activity. This CE activity is approved for 0.5 contact hour (0.05 CEU) in states that recognize ACPE providers, and is provided at no cost to participants. Completion of an evaluation and post-test with a score of 70% or higher is required to receive CE credit. Proof of completion will be posted in NABP CPE Monitor profiles. No partial credit will be given.
This CE activity is jointly provided by ProCE, Inc. and Wild Iris Medical Education,
Inc. This activity provides 0.5 contact hour of nurse CE credit.
Wild Iris Medical Education, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
No external support has been received for this activity.
The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.